The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Timber Pharmaceuticals, Inc. on January 22, 2024. The debtor has been authorized to sell substantially all its assets to LEO Spiny Merger Sub, Inc. and LEO Pharma A/S for a purchase price of $14.35 million in cash plus the assumption of the assumed liabilities.